Portfolio of Generic Drug Stocks
Here are 4 major generic drug companies.
| 4 Generic Drug Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Lannett Company | LCI | |
| Perrigo | PRGO | |
| Teva Pharmaceuticals | TEVA | |
| Viatris | VTRS | |
| Sparkline weekly price charts based on Alpha Vantage data. | ||
| 4 Generic Drug Stocks | ||
|---|---|---|
Name | Symbol | Last Close |
| Lannett Company | LCI | $0.46 |
| Perrigo | PRGO | $36.53 |
| Teva Pharmaceuticals | TEVA | $8.23 |
| Viatris | VTRS | $8.72 |
Portfolio Values
To inspect the performance of the Generic Drug Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 3 stocks included in the portfolio computations are: LCI, PRGO and TEVA. The current value of the portfolio assumes that $3,333.33 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. VTRS was excluded from the portfolio computations because of insufficient price data.The current value of the $10,000 investment is $3,723. The percent return is -62.77%. The annualized return is -17.93%.
| 3 Generic Drug Stocks Returns | ||
|---|---|---|
Name | Symbol | Monthly Returns & Details |
| Lannett Company | LCI | -97.69% |
| Perrigo | PRGO | -50.59% |
| Teva Pharmaceuticals | TEVA | -40.02% |
Portfolio Value Chart for Last 100 Daily Closes